Abstract: Oligonucleotides are provided herein that inhibit TMPRSS6 expression. Also provided are compositions including the same and uses thereof, particularly uses relating to treating diseases, disorders and/or conditions associated with hepcidin deficiency or suppression. 5
| # | Name | Date |
|---|---|---|
| 1 | 202547001692-STATEMENT OF UNDERTAKING (FORM 3) [08-01-2025(online)].pdf | 2025-01-08 |
| 3 | 202547001692-Sequence Listing in PDF [08-01-2025(online)].pdf | 2025-01-08 |
| 4 | 202547001692-PROOF OF RIGHT [08-01-2025(online)].pdf | 2025-01-08 |
| 5 | 202547001692-PRIORITY DOCUMENTS [08-01-2025(online)].pdf | 2025-01-08 |
| 6 | 202547001692-POWER OF AUTHORITY [08-01-2025(online)].pdf | 2025-01-08 |
| 7 | 202547001692-FORM 1 [08-01-2025(online)].pdf | 2025-01-08 |
| 8 | 202547001692-FIGURE OF ABSTRACT [08-01-2025(online)].pdf | 2025-01-08 |
| 9 | 202547001692-DRAWINGS [08-01-2025(online)].pdf | 2025-01-08 |
| 10 | 202547001692-DECLARATION OF INVENTORSHIP (FORM 5) [08-01-2025(online)].pdf | 2025-01-08 |
| 11 | 202547001692-COMPLETE SPECIFICATION [08-01-2025(online)].pdf | 2025-01-08 |
| 12 | 202547001692-FORM 18 [09-01-2025(online)].pdf | 2025-01-09 |
| 13 | 202547001692-FORM 3 [07-07-2025(online)].pdf | 2025-07-07 |
| 14 | 202547001692-PA [22-09-2025(online)].pdf | 2025-09-22 |
| 15 | 202547001692-ASSIGNMENT DOCUMENTS [22-09-2025(online)].pdf | 2025-09-22 |
| 16 | 202547001692-8(i)-Substitution-Change Of Applicant - Form 6 [22-09-2025(online)].pdf | 2025-09-22 |